Last reviewed · How we verify
Vehicle of ADX-102 Topical Dermal Cream
Vehicle of ADX-102 Topical Dermal Cream is a Complement inhibitor Small molecule drug developed by Aldeyra Therapeutics, Inc.. It is currently in Phase 3 development for Vernal keratoconjunctivitis, Atopic keratoconjunctivitis.
ADX-102 is a topical dermal cream that targets the complement pathway to reduce inflammation.
ADX-102 is a topical dermal cream that targets the complement pathway to reduce inflammation. Used for Vernal keratoconjunctivitis, Atopic keratoconjunctivitis.
At a glance
| Generic name | Vehicle of ADX-102 Topical Dermal Cream |
|---|---|
| Sponsor | Aldeyra Therapeutics, Inc. |
| Drug class | Complement inhibitor |
| Target | Complement component 3 (C3) |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology, Dermatology |
| Phase | Phase 3 |
Mechanism of action
By inhibiting the complement pathway, ADX-102 aims to reduce inflammation and alleviate symptoms associated with various ocular and skin conditions. This mechanism is particularly relevant for conditions characterized by complement-mediated inflammation.
Approved indications
- Vernal keratoconjunctivitis
- Atopic keratoconjunctivitis
Common side effects
- Eye irritation
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vehicle of ADX-102 Topical Dermal Cream CI brief — competitive landscape report
- Vehicle of ADX-102 Topical Dermal Cream updates RSS · CI watch RSS
- Aldeyra Therapeutics, Inc. portfolio CI
Frequently asked questions about Vehicle of ADX-102 Topical Dermal Cream
What is Vehicle of ADX-102 Topical Dermal Cream?
How does Vehicle of ADX-102 Topical Dermal Cream work?
What is Vehicle of ADX-102 Topical Dermal Cream used for?
Who makes Vehicle of ADX-102 Topical Dermal Cream?
What drug class is Vehicle of ADX-102 Topical Dermal Cream in?
What development phase is Vehicle of ADX-102 Topical Dermal Cream in?
What are the side effects of Vehicle of ADX-102 Topical Dermal Cream?
What does Vehicle of ADX-102 Topical Dermal Cream target?
Related
- Drug class: All Complement inhibitor drugs
- Target: All drugs targeting Complement component 3 (C3)
- Manufacturer: Aldeyra Therapeutics, Inc. — full pipeline
- Therapeutic area: All drugs in Ophthalmology, Dermatology
- Indication: Drugs for Vernal keratoconjunctivitis
- Indication: Drugs for Atopic keratoconjunctivitis
- Compare: Vehicle of ADX-102 Topical Dermal Cream vs similar drugs
- Pricing: Vehicle of ADX-102 Topical Dermal Cream cost, discount & access